Skip to main content
Total HealthSupply
Triamcinolone Acetonide Injectable Suspension, USP, 40 mg/mL, 1 mL Single-Dose Vial
Available to order

Triamcinolone Acetonide Injectable Suspension, USP, 40 mg/mL, 1 mL Single-Dose Vial

SKU AMN 70121104902

$7.40

Selling unit is not specified. Confirm the selling unit with customer care before ordering if unclear.

Purchase options

Request quote
Brand
Amneal BioServices LLC

Categories

Product details

Product Specifications

Specification Details
Manufacturer / Brand Amneal Biosciences LLC
Manufacturer # / SKU 70121104902
NDC Number 70121-1049-02
Active Ingredient Triamcinolone Acetonide
Concentration 40 mg / mL
Volume 1 mL
Container Type Single-Dose Vial (SDV)
Application Glucocorticoid / Anti-inflammatory
Route of Admin Intramuscular (IM) / Intra-articular
Storage Store at 20°C to 25°C; Do Not Freeze
Packaging / Sold As Individual 1 mL Vial
UNSPSC Code 51101807

Key Features

  • Extended Release Profile: Provides prolonged therapeutic effects, making it ideal for managing chronic inflammatory states with fewer injections.

  • Versatile Administration: Indicated for systemic therapy via deep intramuscular injection or localized treatment via intra-articular or soft tissue injection.

  • Preservative-Free Option: This single-dose vial configuration is designed for immediate use, minimizing the risks associated with multi-dose contamination.

  • Standard Potency: The 40 mg/mL concentration is the clinical standard for adult dosing in rheumatology and dermatology.

  • Micronized Suspension: Formulated for smooth delivery through a range of needle gauges, ensuring consistent dosing.

Clinical Applications

  • Rheumatology: Intra-articular injection for the short-term management of acute episodes or exacerbations of osteoarthritis, rheumatoid arthritis, and bursitis.

  • Dermatology: Intralesional administration for conditions such as keloids, discoid lupus erythematosus, and localized hypertrophic lesions.

  • Allergic States: Intramuscular use for control of severe or incapacitating allergic conditions (e.g., asthma, contact dermatitis) when conventional treatments fail.

  • Endocrine Disorders: Used for primary or secondary adrenocortical insufficiency.

⚠️ Usage Note: Not for Intravenous (IV) use. This product is a suspension and must be shaken well before use to ensure a uniform dose.

⚠️ Safety: Do not inject into unstable joints. Frequent intra-articular injection may result in joint tissue damage. Avoid injection into an infected site.

⚠️ Side Effects: May cause localized skin depigmentation or atrophy at the injection site if not administered into the deep muscle or joint space correctly.